ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 152 filers reported holding ARRAY BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,298,000 | -20.8% | 94,275 | -47.0% | 0.56% | +16.8% |
| Q1 2018 | $2,901,000 | +38.3% | 177,747 | +8.5% | 0.48% | +28.5% |
| Q4 2017 | $2,097,000 | -15.7% | 163,818 | -19.0% | 0.38% | +13.6% |
| Q3 2017 | $2,488,000 | +321.7% | 202,309 | +201.2% | 0.33% | +324.4% |
| Q4 2016 | $590,000 | -40.0% | 67,178 | -53.9% | 0.08% | -40.9% |
| Q3 2016 | $983,000 | -10.6% | 145,682 | -2.3% | 0.13% | +3.9% |
| Q1 2015 | $1,099,000 | – | 149,121 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |